Opioid-sparing effects of a low-dose infusion of naloxone in patient- administered morphine sulfate

Anesthesiology

Volumn 87, Issue 5, 1997, Pages 1075-1081

  Gan, Tong J ^a   Ginsberg, Brian ^b   Glass, Peter S A ^b   Fortney, Jennifer ^b   Jhaveri, Rajiv ^b   Perno, Rhonda ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Analgesia: patient controlled; postoperative; Analgesics, opioid: morphine; Anesthetic technique: general; Antagonist, opioid: naloxone; Complications, postoperative: nausea; vomiting; pruritus

Indexed keywords

ANESTHETIC AGENT; FENTANYL; ISOFLURANE; MIDAZOLAM; MORPHINE SULFATE; NALOXONE; OPIATE; OXYHEMOGLOBIN; PROMETHAZINE; THIOPENTAL; VECURONIUM;

ARTICLE; BLOOD PRESSURE; BREATHING RATE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NAUSEA; PAIN; PATIENT CONTROLLED ANALGESIA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ADULT; AGED; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MIDDLE AGED; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN, POSTOPERATIVE;

EID: 0030730101     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199711000-00011     Document Type: Article

References (23)

1. Rawal N, Schott U, Dahlstrom B, Inturrisi CE, Tandon B, Sjostrand U, Wennhager M: Influence of naloxone infusion on analgesia and respiratory depression following epidural ANESTHESIOLOGY 1986; 64:194-201
2. Gueneron JP, Ecoffey C, Carli P, Benhamou D, Gross JB: Effect of naloxone infusion on analgesia and respiratory depression after epidural fentanyl. Anesth Analg 1988; 67:35-8
3. Johnson A, Bengtsson M, Lofstrom JB, Rane A, Wahlstrom A: Influence of postoperative naloxone infusion on respiration and pain relief after intrathecal morphine. Reg Anesth 1988; 13:146-51
4. Ramsay MAE, Savege TM, Goodwin R: Controlled sedation with alphaxalone-alphadolone. BMJ 1974; 2:656-9
5. Hecker BR, Albert L: Patient-controlled analgesia: a randomized, prospective comparison between two commercially available PCA pumps and conventional analgesic therapy for postoperative pain. Pain 1988; 35:115-20
6. Wright PM, O'Toole DP, Barron DW: The influence of naloxone infusion on the action of intrathecal diamorphine: low-dose naloxone and neuroendocrine responses. Acta Anaesthesiol Scand 1992; 36:230-3
7. Woolf CJ: Analgesia and hyperalgesia produced in the rat by intrathecal naloxone. Brain Res 1980; 189:593-7
8. Ngai SH, Berkowitz BA, Yang JC, Hempstead J, Spector S: Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action. ANESTHESIOLOGY 1976; 44:398-401
9. Glass PS, Jhaveri RM, Smith LR: Comparison of potency and duration of action of nalmefene and naloxone. Anesth Analg 1994; 78:536-41
10. Ueda H, Fukushima N, Kitao T, Ge M, Tagaki H: Low doses of naloxone produce analgesia in the mouse brain by blocking presynaptic autoinhibition of enkephalin release. Nerosci Lett 1986; 65:247-52
11. Levine JD, Gordon NC: Method of administration determines the effect of naloxone on pain. Brain Res 1986; 365:377-8
12. Levine JD, Gordon NC, Fields HL: Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature 1979; 278:740-1
13. Miaskowski C, Taiwo YO, Levine JD: Intracerebroventricular naloxone produces a dose-dependent, monotonie increase in nociceptive threshold in the rat. Brain Res 1990; 515:323-5
14. Childers SR, Creese I, Snowman AM, Snyder SH: Opiate receptor binding affected differentially by opiates and opioid peptides. Eur J Pharmacol 1979; 55:11-18
15. Kurashi Y, Sugimoto M, Hamada T, Kayanoki Y, Takagi H: Noxious stimuli and Met-enkephalin release from nucleus reticularis gigantocelluralis. Brain Research Bulletin 1984; 12:123-7
16. Langer SZ, Arbilla S: Presynaptic receptors and modulation of the release of noradrenaline, dopamine and GABA. Postgrad Med J 1981; 57:18-29
17. Costall B, Hui SC, Naylor RJ: Differential actions of substituted benzamides on pre- and postsynaptic dopamine receptor mechanisms in the nucleus accumbens. J Pharm Pharmacol 1980; 32:594-6
18. Raffa RB: A novel approach to the pharmacology of analgesics. Am J Med 1996; 101:40S-46S
19. Stein C: Peripheral analgesic actions of opioids. Journal of Pain Symptom Management 1991; 6:119-24
20. Colado MI, Martin MI: Effects of opioid and alpha 2-adrenoceptor agonists on the isolated ileum of morphine-dependent guinea-pigs during withdrawal and after clonidine treatment. J Pharm Pharmacol 1992; 44:101-4
21. Paronis CA, Holtzman SG: Increased analgesic potency of mu agonists after continuous naloxone infusion in rats. J Pharmacol Exp Ther 1991; 259:582-9
22. Yoburn BC, Nunes FA, Adler B, Pasternak GW, Inturrisi CE: Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse. J Pharmacol Exp Ther 1986; 239:132-5
23. Schwinn DA, Leone BJ, Spahn DR, Chesnut LC, Page SO, McRae RL, Liggett SB: Desensitization of myocardial beta-adrenergic receptors during cardiopulmonary bypass. Evidence for early uncoupling and late downregulation. Circulation 1991; 84:2559-67